23andMe announced the launch of the Lupus Research Study in collaboration with Pfizer.
The companies aim to enroll 5,000 individuals with systemic lupus erythematosus, more commonly known as lupus, into the study to help better understand the genetics of lupus.
The effort is also in collaboration with the Lupus Research Institute, and in concert with Lupus Awareness Month in May.
n addition to genetic information and survey questions, 23andMe will incorporate data from participants' medical records into this research study after obtaining their consent.
This data will be used in the analysis of longitudinal surveys with participants over the course of one year.
|Searching for more deal information? Current Partnering offers the following options:|
For further deal information visit Current Agreements (subscription required)
Scorecard: Top partnering deals by value in 2015
View: Top biotech companies